![Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection | Stroke Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection | Stroke](https://www.ahajournals.org/cms/asset/9ec81ceb-13c2-4de3-bf82-97cba10527b6/zhs0011263100001.jpeg)
Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection | Stroke
![JPM | Free Full-Text | SLCO1B1 Phenotype and CYP3A5 Polymorphism Significantly Affect Atorvastatin Bioavailability JPM | Free Full-Text | SLCO1B1 Phenotype and CYP3A5 Polymorphism Significantly Affect Atorvastatin Bioavailability](https://www.mdpi.com/jpm/jpm-11-00204/article_deploy/html/images/jpm-11-00204-g001.png)
JPM | Free Full-Text | SLCO1B1 Phenotype and CYP3A5 Polymorphism Significantly Affect Atorvastatin Bioavailability
![Association between CYP2C19 and CYP2B6 phenotypes and the pharmacokinetics and safety of diazepam - ScienceDirect Association between CYP2C19 and CYP2B6 phenotypes and the pharmacokinetics and safety of diazepam - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332222011362-ga1.jpg)
Association between CYP2C19 and CYP2B6 phenotypes and the pharmacokinetics and safety of diazepam - ScienceDirect
![Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial | medRxiv Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2020/08/07/2020.08.03.20167502/F1.large.jpg)
Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial | medRxiv
![Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial | medRxiv Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2020/08/07/2020.08.03.20167502/F2.large.jpg)
Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial | medRxiv
![PDF) Substrate Fate in Activated Macrophages: A Comparison between Innate, Classic, and Alternative Activation PDF) Substrate Fate in Activated Macrophages: A Comparison between Innate, Classic, and Alternative Activation](https://i1.rgstatic.net/publication/44626386_Substrate_Fate_in_Activated_Macrophages_A_Comparison_between_Innate_Classic_and_Alternative_Activation/links/00b4951da84e77cce2000000/largepreview.png)
PDF) Substrate Fate in Activated Macrophages: A Comparison between Innate, Classic, and Alternative Activation
![Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics | Advances in Therapy Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics | Advances in Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-020-01566-w/MediaObjects/12325_2020_1566_Fig3_HTML.png)
Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics | Advances in Therapy
![PDF) Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial PDF) Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial](https://i1.rgstatic.net/publication/343520609_Safety_and_cardiovascular_effects_of_multiple-dose_administration_of_aripiprazole_and_olanzapine_in_a_randomised_clinical_trial/links/5f311beea6fdcccc43bb5496/largepreview.png)
PDF) Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial
![ABCB1 C3435T, G2677T/A and C1236T variants have no effect in eslicarbazepine pharmacokinetics - ScienceDirect ABCB1 C3435T, G2677T/A and C1236T variants have no effect in eslicarbazepine pharmacokinetics - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332221008660-ga1.jpg)
ABCB1 C3435T, G2677T/A and C1236T variants have no effect in eslicarbazepine pharmacokinetics - ScienceDirect
![Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection | Stroke Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection | Stroke](https://www.ahajournals.org/cms/asset/d9685aba-ed8e-40d5-97a8-34498bd3d967/zhs0011263100005.jpeg)
Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection | Stroke
![Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers - ScienceDirect Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332220312804-ga1.jpg)
Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers - ScienceDirect
![Effective phospholipids removing microelution-solid phase extraction LC-MS/MS method for simultaneous plasma quantification of aripiprazole and dehydro-aripiprazole: Application to human pharmacokinetic studies - ScienceDirect Effective phospholipids removing microelution-solid phase extraction LC-MS/MS method for simultaneous plasma quantification of aripiprazole and dehydro-aripiprazole: Application to human pharmacokinetic studies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0731708517322719-gr1.jpg)
Effective phospholipids removing microelution-solid phase extraction LC-MS/MS method for simultaneous plasma quantification of aripiprazole and dehydro-aripiprazole: Application to human pharmacokinetic studies - ScienceDirect
![Effective quantification of 11 tyrosine kinase inhibitors and caffeine in human plasma by validated LC-MS/MS method with potent phospholipids clean-up procedure. Application to therapeutic drug monitoring - ScienceDirect Effective quantification of 11 tyrosine kinase inhibitors and caffeine in human plasma by validated LC-MS/MS method with potent phospholipids clean-up procedure. Application to therapeutic drug monitoring - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0039914019310835-fx1.jpg)
Effective quantification of 11 tyrosine kinase inhibitors and caffeine in human plasma by validated LC-MS/MS method with potent phospholipids clean-up procedure. Application to therapeutic drug monitoring - ScienceDirect
![Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection | Stroke Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection | Stroke](https://www.ahajournals.org/cms/asset/c3dd72d6-3029-48d1-82dd-d723e5fadb98/zhs0011263100004.jpeg)